Another seasonal trend is the four-year U.S. presidential cycle. In general, the market rises modestly in the first year after a presidential election, followed by trouble in the second year. In years ...

Q4 2024 Management View CEO Patrick Kaltenbach highlighted a strong finish to 2024 with excellent performance in laboratory products, particularly in Europe. He emphasized the company’s focus on ...

Nektar Therapeutics (NKTR) has been beaten down lately with too much selling pressure. While the stock has lost 38.5% over ...